IDH-125

N/A

Report date: 2023/05/22 10:19:16

NME

Base Information

Drug NameIDH-125

Drug Alias NameIDH-125

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionIsocitrate dehydrogenase [NADP] cytoplasmic inhibitors

TargetsIsocitrate dehydrogenase [NADP] cytoplasmic

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A